Product name:CIPROFLOXACIN HYDROCHLORIDE
Company name:
DIN:02239091
Status:Marketed
Status date:2012-05-17
| Active ingredient(s) | Strength |
|---|---|
| HYDROCHLORIDE HYDROCHLORIDE (CIPROFLOXACIN HYDROCHLORIDE) | 250 MG / 1 ML |
Click on a resource to visit a page with more information. You may be taken away from this page to a different Government of Canada website.
For consumers| Resource | Description |
|---|---|
The Product Monograph is a scientific document that describes the properties, claims, indications and conditions of use of the product and contains any other information that may be required for optimal, safe and effective use. The Product Monograph includes three sections:
| |
Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are:
|
Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals. |
| After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes. |
This is a generic form of Ciprofloxacinand is available without a prescription in the USA for$2.24.
The generic version of Ciprofloxacin (ciprofloxacin) isCiprofloxacin HCl, the generic version isCiprofloxacin HCl Oral Suspension, and the price is$2.17
This article details the pricing for Ciprofloxacin and Ciprofloxacin Oral Suspension.
See thein Ciprofloxacin prices for more information.in the Ciprofloxacin prices for more information.The cost for Ciprofloxacin is$2.29for the generic version.
Ciprofloxacin is available as a10-capsuletablet.
Forof the generic price, Ciprofloxacin is$2.84for the 10-capsule form.
The generic and the 10-capsule versions of Ciprofloxacin Oral Suspension are, the generic version of Ciprofloxacin is
The 10-capsule version of Ciprofloxacin Oral Suspension isCiprofloxacin Oral Suspension
Ciprofloxacin Oral Suspension 10-capsule prices are
Ciprofloxacin Oral Suspension prices are, the generic version of Ciprofloxacin Oral Suspension is
, the generic version of Ciprofloxacin HCl Oral Suspension is
Treatment of bacterial infections of the lungs, nose, ear, bones and joints, skin and soft tissue, kidney, bladder, abdomen, and genitals caused by ciprofloxacin-susceptible organisms. Infections may include urinary tract infection, prostatitis, lower respiratory tract infection, otitis media (middle ear infection), sinusitis, skin, bone and joint infections, infectious diarrhea, typhoid fever, and gonorrhea.
May be taken with or without food. May be taken w/ meals to minimise GI discomfort. Do not take w/ antacids, Fe or dairy products.
Hypersensitivity to ciprofloxacin or other quinolones. History or risk of QT prolongation; known history of myasthenia gravis. Concomitant use with tizanidine.
Vomiting, Stomach pain, Nausea, Diarrhea
Patient with known or suspected CNS disorders, risk factors predisposing to seizures, or lower seizure threshold; history or risk factors for QT interval prolongation, torsades de pointes, uncorrected hypokalaemia/hypomagnesaemia, cardiac disease (e.g. heart failure, MI, bradycardia); positive family history of aneurysm disease, pre-existing aortic aneurysm or dissection and its risk factors (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, hypertension, peripheral atherosclerotic vascular disease); diabetes, previous tendon disorder (e.g. rheumatoid arthritis), G6PD deficiency. Renal and hepatic impairment. Elderly, children. Pregnancy and lactation.
Store between 20-25°C.
Quinolones
Availability: In UK or USPorossian (ciprofloxacin)Other quinolones
PorossianMarfan syndrome, vascular Ehlers-Danlos syndrome, hypertension, peripheral atherosclerotic vascular disease); diabetes. e.g. rheumatoid arthritis. Geriatric patients: elderly patients taking other quinolones have higher incidence of sepsis and longer illness proclivity. Patients taking other medicines listed here may need to be closely monitored on medicines with known with or without probable interaction with ciprofloxacin. Patients taking ciprofloxacin should also be advised to avoid taking potassium supplements or potassium-sparing diuretics, as these may reduce the effectiveness of ciprofloxacin. Patients taking other drugs listed here may need to be mindful of the possibility of drug interactions with these compounds. Caution is advised when using ciprofloxacin with other drugs belonging to the tizanidine family. - Use with caution in patients with hepatic disease (see Drugs and Biological Products under.
May be taken w/ medicines or food taken for no apparent reason
ciprofloxacin
Hepatitis A, bv and bv subtypes, liver and kidney disease, HIV infection, bone and joint infections, infectious diarrhea, typhoid fever, and gonorrhea.
In the United States, the price of Ciprofloxacin in the U. S. has gone up by over 50 percent, according to a report by theMedscape Medical News.
The price of Ciprofloxacin in the U. has risen to around $1 a tablet, a small price hike for the drug. The drug, also sold under the brand name Cipro, has not been included in theMedscapereport.
The price of Ciprofloxacin, also known as ciprofloxacin, has gone up from $1 to $7 for 30 tablets to $7 to $4 a pill, according to a news release from the FDA. The drug is manufactured in a lab in the U. S., and is available as an over-the-counter product.
It is not clear how much the drug will cost, but the drug is expected to cost around $10 for a 30-tablet bottle. Other manufacturers, including Teva Pharmaceuticals, have recently lowered prices to $1 and $3 per tablet, respectively, due to a reduction in manufacturing costs and the increased production of the drug. The company's report states that it is "working on lowering price by 20 to 30 percent, and the drug’s cost remains the same."
has gone up by over 50 percent, according to the report. The drug is also available under the brand name Cipro and is manufactured in a lab in the U. S., but is marketed as a treatment for a rare form of urinary tract infection known as pyelonephritis, which affects both men and women. The drug's price in the U. has increased to around $10 a tablet from $1 to $4 a pill.
has gone up by over 50 percent since the first quarter of 2024, according to a news release from the FDA.
The drug is available under the brand name Cipro and is marketed as an over-the-counter medication. The drug is also sold under the brand name Cipro and is manufactured in a lab in the U.
has gone up by over 50 percent since the first quarter of 2024, according to the report.
The drug's price has increased by nearly 50 percent since the first quarter of 2024. The drug was the top-selling drug on the market in the U. in 2024, with sales of $4.6 billion. However, Ciprofloxacin, which is used to treat infections caused by bacteria, has been the most popular drug in the U. since its approval in 1987.
The company has also increased the price of the drug by 25 percent since its initial approval. The drug has been available under the brand name Cipro. The drug is sold under the brand name Cipro and is marketed as a treatment for bacterial infections.
Cipro is currently the only treatment for bacterial infections in men. It is also used for other infections. In some cases, it may be used for purposes other than those listed in the drug's list of approved uses.
has also increased by 50 percent since the first quarter of 2024.
The drug's cost is expected to cost around $10 per tablet. According to the drug's manufacturer, Teva Pharmaceuticals, the price of the drug will increase by a maximum of $5 per tablet. However, the price of Cipro will be lower compared to the market, which currently has an average retail price of around $5 per tablet.
Teva Pharmaceuticals estimates that the drug will cost between $5 and $10 a tablet from now through December 2024, depending on the pharmacy and location. The company will start selling the drug in the U. by April 2025.
Getty ImagesCiprofloxacin is sold under the brand name Cipro and is manufactured by Teva Pharmaceuticals.
The drug is sold under the brand name Cipro and is manufactured by Teva Pharmaceuticals.
The price of the drug in the U.
Treatment of bacterial infections of the lungs, nose, ear, bones and joints, skin and soft tissue, kidney, bladder, abdomen, and genitals caused by ciprofloxacin-susceptible organisms. Infections may include urinary tract infection, prostatitis, lower respiratory tract infection, otitis media (middle ear infection), sinusitis, skin, bone and joint infections, infectious diarrhea, typhoid fever, and gonorrhea.
May be taken with or without food. May be taken w/ meals to minimise GI discomfort. Do not take w/ antacids, Fe or dairy products.
Hypersensitivity to ciprofloxacin or other quinolones. History or risk of QT prolongation; known history of myasthenia gravis. Concomitant use with tizanidine.
Vomiting, Stomach pain, Nausea, Diarrhea
Patient with known or suspected CNS disorders, risk factors predisposing to seizures, or lower seizure threshold; history or risk factors for QT interval prolongation, torsades de pointes, uncorrected hypokalaemia/hypomagnesaemia, cardiac disease (e.g. heart failure, MI, bradycardia); positive family history of aneurysm disease, pre-existing aortic aneurysm or dissection and its risk factors (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, hypertension, peripheral atherosclerotic vascular disease); diabetes, previous tendon disorder (e.g. rheumatoid arthritis), G6PD deficiency. Renal and hepatic impairment. Elderly, children. Pregnancy and lactation.
Store between 20-25°C.
Quinolones
icsTuberculosis (TB) and gynocomITAL cancer. TB is a�vasculardisease that causes skin and soft tissue injuries, including blood disorders, such as aortic dissection, vascular Ehlers-Danlos syndrome, Henoch-Schirable anemia, peripheral atherosclerotic vascular disease, and secondary MI. Secondary MI, in particular, results from systemic lupus erythematosus (SLE), a disease that is found in more than 1 in 100 people with the condition. Secondary connective tissue disease (STPD), a condition that is also found in systemic connective tissue disorders like connective tissue mycobacteria and rhabdomyolysis. Primary connective tissue disorders like retinitis pigmentosa, Stevens-Johnson syndrome, toxic epidermal necrolysis (TEN), toxic liver injury (ALT), and empyema require a higher index of suspicion and are therefore considered differential conditions.
Drugs used to treat hyperglycaemia (high blood sugar) or insulin resistance (low blood insulin sensitivity) in type 2 diabetic patients. Trazodone (Zanaflex) is used to treat hyperglycaemia (high blood sugar) or insulin resistance (low blood insulin sensitivity). The use of Trazodone in diabetic patients without prior type 2 diabetes mellitus or insulin resistance is contraindicated. The combination of these two agents may lead to hyperglycaemia or insulin resistance. The use of Trazodone with metformin may cause hyperglycaemia (high blood sugar).
General principles of medical pharmacology. Trazodone should be used with caution in patients with a history of hypersensitivity to ciprofloxacin or other quinolones. The drug should also be used with caution in patients with a history of systemic lupus erythematosus (SLE). Close monitoring of body weight, blood sugar levels, and blood electrolyte levels is recommended.
Stade de France Pharmacy